uniQure N.V. (QURE) Stock Price

QUREStock
$51.05+202.29%52W
Market Cap$3.54B
P/E
PEG Ratio
Div yield
Beta0.91

QURE Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)91.31%
Price vs S&P 500 (4W)26.41%
VGM Score52.84

QURE Earnings Surprise History

Q2 25-0.60est. -0.76
Q3 25-1.19est. -0.75
Q4 25-0.47est. -0.78
Q1 26-0.73est. -0.75
Q2 26-1.07est. -0.71

QURE Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
4.05
4.05
4.14
4.25

Industry Peers — Pharmaceuticals(571)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
QUREuniQure N.V.
DCA$51.05
LLYEli Lilly & Co.DBB$1233.66
JNJJohnson & JohnsonDCB$273.14
ABBVABBVIE INC.DCB$265.79
MRKMerck & Co., Inc.DCA$156.45
NVSNovartis AGCCC$159.98
AZNAstraZeneca PLCCBC$169.66
NVONovo-Nordisk A/SBCC$48.66
ABTAbbott LaboratoriesCCB$116.13
PFEPfizer Inc.CDC$28.57
VRTXVertex Pharmaceuticals IncDCB$552.85

About uniQure N.V.

uniQure NV is a gene therapy company developing treatments for hemophilia, Huntington's disease, and cardiovascular diseases. The company has established a collaboration with Bristol Myers Squibb to advance its cardiovascular gene therapy pipeline.